Navigation Links
Cytopia Presentation on VDA CYT997 at AACR Conference
Date:4/15/2009

MELBOURNE, Australia, April 15 /PRNewswire/ -- Cytopia Limited (ASX: CYT) announced that it will present data on its anticancer vascular disrupting agent (VDA) CYT997 at the forthcoming 100th Annual Meeting of the American Association for Cancer Research, in Denver, Colorado, USA.

Dr David Segal, Principal Scientist at Cytopia, will be presenting the poster in the Late-Breaking Research: Experimental and Molecular Therapeutics 2 poster session on Tuesday, April 21, 2009 from 8:00 AM to 2:00 PM (US MDT), Hall BF, Poster Section 26, Poster Board 18.

The poster, entitled CYT997: Preclinical studies on the antivascular effects and mode of action of a Phase II vascular disrupting agent outlines extensive preclinical data for CYT997 which is currently in Phase II clinical studies. Data for CYT997 in a panel of in vitro and in vivo assays will be shown clearly demonstrating the potent antivascular and cytotoxic effects of the compound.

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through subsidiaries based in Melbourne, Australia and San Francisco, USA and specializes in developing new small molecule compounds with an improved therapeutic profile for the treatment of cancer.

The company's lead drug candidate is CYT997, a vascular disrupting agent (VDA) for the treatment of various cancers, which is currently being trialed in Phase II clinical studies. Cytopia is continuing to build on its range of JAK inhibitors and kinase expertise, with CYT387, a novel oral JAK2 inhibitor focused on the treatment of myeloproliferative disorders, expected to enter Phase I clinical studies in 2009.

Website: www.cytopia.com.au

'/>"/>
SOURCE Cytopia Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
2. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
3. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
4. Cytopia and Other Progen Shareholders Maintain Call for Meeting
5. Cytopia Letter to Progen Shareholders
6. Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
7. Strategic Diagnostics Updates Roth Conference Presentation Time
8. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
9. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
10. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
11. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Rainbow Scientific, Inc. (RSI), ... recently opened an online store to add customer ... lines developed and manufactured by Biological Industries, Inc. ... Biological Industries’ Nutristem® serum-free, xeno-free reagents for human ... cell (hESC) culture. , The online store ...
(Date:9/30/2014)... Whitehouse, New Jersey (PRWEB) September 30, 2014 ... that it has been chosen by the Parenteral ... course (November 18 and 19, 2014) on container closure ... current container closure integrity test methods and philosophies detailed ... Product – Integrity Evaluation. The course will ...
(Date:9/29/2014)... (PRWEB) September 30, 2014 Each ... burn injuries require medical attention. In the military, ... serious complications to battlefield medical care. More than ... and Afghanistan. Burn wounds heal slowly, remain inflamed ... be excessive, physically debilitating and functionally damaging. While ...
(Date:9/29/2014)... Sept. 29, 2014  Ten of the most ... cartilage repair, regeneration, allograft reconstruction and research and ... world gathered to discuss the future of cartilage ... Regenerative Medicine symposium, Cartilage Regeneration: State of ... Orthopedic Biosurgery, Minced Juvenile Allograft, and State of ...
Breaking Biology Technology:Rainbow Scientific, Inc. opens online store for state-of-the-art stem cell culture and cytogenetic reagents 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4Faster Healing with Fewer Scars 2World Renowned Experts Discuss Future Of Cartilage Regeneration 2World Renowned Experts Discuss Future Of Cartilage Regeneration 3
... , DeKalb, Ill. Scientists at Northern Illinois University ... high yields of graphene, a highly touted carbon nanostructure ... fabric of the future. The focus of intense ... material, comprised of a single layer of carbon atoms ...
... Netsmart Technologies, Inc. ( www.ntst.com ... for health and human services organizations, today announced ... software for behavioral health provider organizations has achieved ... (Logo: http://photos.prnewswire.com/prnh/20110620/NY22778LOGO) "We are fully committed ...
... Neogen Corporation (NASDAQ: NEOG ) announced today ... seafood testing laboratory from its parent company, GlycoMar Ltd. ... services to the shellfish and salmon aquaculture industries. VeroMara,s ... including E. coli , noroviruses, and salmon husbandry. ...
Cached Biology Technology:Northern Illinois University scientists find simple way to produce graphene 2CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 2CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 3CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification 4Neogen Acquires VeroMara from GlycoMar Ltd. 2
(Date:9/30/2014)... to tetrachloroethylene (PCE) in drinking water may increase ... to a new study led by a Boston ... study, published in the journal Environmental Health ... pregnancies among 1,766 women in Cape Cod, Ma., ... to the early 1980s by the installation of ...
(Date:9/30/2014)... live in almost any aquatic environment on Earth, but ... species are pushed to the limit. The amount of ... critical for how different species cope in the future, ... of Gothenburg, published in the scientific journal Proceedings ... continues apace thanks to increasing levels of greenhouse gases ...
(Date:9/30/2014)... and farm runoff in Hawaii is causing tumors in ... The study, published Tuesday in the peer-reviewed open-access journal ... ends up in algae that the turtles eat, promoting ... and internal organs. , Scientists at Duke University, the ... Administration (NOAA) conducted the study to better understand the ...
Breaking Biology News(10 mins):Contaminated water linked to pregnancy complications, BU study finds 2Shape up quickly -- applies to fish, too! 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... is available in German . , What is ... what do they mean for the nutrition and balance of a ... growing data streams even in mobile internet access? How do the ... this view imply for the interpretation of artistic creations in general? ...
... Singapore, May 9, 2012 Researchers at the ... bioengineering and nanotechnology research institute, have developed a miniaturized ... stem cells (CSCs). Published recently in Nano Today ... more effective cancer drugs. In a tumor, CSCs ...
... on behalf of the European Pet Food Industry Federation ... A consumption for puppies. The research marks a significant ... vitamin A levels for puppies and sheds new light ... was conducted by scientists from the Free University of ...
Cached Biology News:DFG establishes 10 new priority programs 2DFG establishes 10 new priority programs 3IBN's Droplet Array sheds light on drug-resistant cancer stem cells 2IBN's Droplet Array sheds light on drug-resistant cancer stem cells 3Collaborative research team identifies safe upper level for vitamin A consumption for puppies 2
Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
Bovine Pulmonary Artery Endothelial Cells (BPAEC) (>500,000 cells)...
Bovine Aortic Smooth Muscle Cells (BAOSMC) (>500,000 cells)...
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
Biology Products: